发明名称 DEPLETION OF IL23R EXPRESSING CELLS IN THE TREATMENT OF VARIOUS DISEASES
摘要 The present invention relates, for example, to depletion of IL23R expressing cells in the treatment of disease and, in an embodiment thereof, to bispecific constructs that specifically bind to immune effector cells and, simultaneously, to IL23R-carrying target cells, as well as nucleic acids, vectors, host cells, pharmaceutical compositions, and methods of production and use thereof, including such bispecific constructs for use in, for example, treating inflammatory and/or autoimmune diseases and/or cancer.
申请公布号 US2015329637(A1) 申请公布日期 2015.11.19
申请号 US201514715398 申请日期 2015.05.18
申请人 NUMAB AG 发明人 URECH David;GUNDE Tea;MEYER Sebastian
分类号 C07K16/28 主分类号 C07K16/28
代理机构 代理人
主权项 1. A method for the treatment of a disease selected from the group consisting of: an inflammatory disease, an autoimmune disease and/or cancer, comprising, in a human patient in need thereof, depleting IL23R expressing cells.
地址 Waedenswil CH